PK/PD modelling and its application in clinical practice
Chairman: G Kenny 

• Indirect response PD modelling. Is the ke0 the panacea?
  F. Mentré (Fr)
  
• Chronobiology and PK/PD modelling in anaesthesia
  B. Lemmer
  
• Target controlled infusion in children.
  X. Viviand (Fr)

Anaesthetic risk assessment and organ protection
Chairman: F. Engbers  

• Cardiac risk assessment and protection for noncardiac surgery
   D. Poldermans (NL)
  

• Intravenous agents and neuroprotection
  C. Werner (Ger)  

• Immunomodulation by intravenous anaesthetic agents HF Galley, Aberdeen (UK)

 Monitoring “depth of anaesthesia”
           Chairman: L. Barvais 

• Does BIS monitoring optimize anaesthetic drug delivery?
  J. Vuyk (NL)
  

• AEP: A clinical or a research tool?
  S. Schraag (Ger)
  

• Three prize winning poster presentations 

  Response Surface Modeling of Propofol-Remifentanil Interaction on Respiratory Control
  DJF Nieuwenhuijs

  Patient Maintained Sedation for Colonoscopy using a Target controlled infusion of Propofol
  G Fletcher

  Effects of epidural anesthesia on the effect site concentrations of propofol in a target-controlled infusion technique
  Y Inagaki

What’s new in NMBA administration?
Chairman: F. Servin  

• Self-learning fuzzy control of neuromuscular blockade
  V. Billard (Fr)
  
• New methods of neuromuscular blockade monitoring T. Fuchs-Buder (Ger)
  
• Clinical relevance of residual neuromuscular blockade L. Eriksson, Stockholm (S)

 Pain perception and control
Chairman: J. Raeder

• The (patho)physiology of pain perception
  S.Mercadante (Ita)
  
• Antinociception by endocannabinoids
  J. Manzanares (Sp)  
  
• Spinal opioids and pain control
  H. Buerkle (Ger)

Miscellaneous
Chairman: A. Borgeat

• Neostigmine and α₂-agonists as additives in neuraxial blockade
  A. Chiari,(Au)
  
• Chirality and cardiotoxicity of anaesthetic agents
  BM Graf (Ger)
  
• Fine-tuning intravenous drug administration
  The Eurosiva Multi-Media team